Core Insights - The formal domestication of the Orbitrap Exploris GC high-resolution mass spectrometer marks a new phase in the localization of high-resolution products [1] Group 1: Investment Potential - On October 17, the list of the top 10 most investment-worthy scientific entrepreneurial companies for 2025 was officially released, with Zhenmai recognized for its technological strength and scale potential in the field of gene sequencing [2] - The selection process involved over a hundred candidate companies across sectors such as AI, clean energy, and high-end medical technology, aiming to anchor high-value investment targets for capital [2] Group 2: Company Achievements - Since 2025, Zhenmai Bio has shown impressive results, completing a C+ round financing of 280 million yuan, which injects momentum for commercialization, globalization, and capacity expansion [5] - On the product technology front, Zhenmai launched the FASTASeq S high-throughput gene sequencer, and the SURFSeq 5000 platform has supported research teams in publishing results in Nature Aging, contributing to over 100 research papers [5] - In terms of market and industry recognition, Zhenmai was listed among the "Top 20 Innovative Companies in the Biomanufacturing Field for 2025," with its equipment entering over 50 countries globally [5]